Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.

Mori T, Ikeda DD, Fukushima T, Takenoshita S, Kochi H.

Cell Cycle. 2011 Oct 1;10(19):3284-99. doi: 10.4161/cc.10.19.17176. Epub 2011 Oct 1.

2.

NIRF/UHRF2 occupies a central position in the cell cycle network and allows coupling with the epigenetic landscape.

Mori T, Ikeda DD, Yamaguchi Y, Unoki M; NIRF Project.

FEBS Lett. 2012 Jun 4;586(11):1570-83. doi: 10.1016/j.febslet.2012.04.038. Epub 2012 Apr 30. Review.

3.

UHRF2, another E3 ubiquitin ligase for p53.

Bai L, Wang X, Jin F, Yang Y, Qian G, Duan C.

Biochem Biophys Res Commun. 2012 Sep 7;425(4):908-11. doi: 10.1016/j.bbrc.2012.08.009. Epub 2012 Aug 9. Retraction in: Biochem Biophys Res Commun. 2013 Nov 1;440(4):803.

PMID:
22902639
4.

Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.

Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ.

J Exp Clin Cancer Res. 2004 Jun;23(2):277-83.

PMID:
15354413
5.

Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.

Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C.

Am J Pathol. 1998 Dec;153(6):1749-65.

6.

Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.

Gugger M, Kappeler A, Vonlanthen S, Altermatt HJ, Ris HB, Lardinois D, Borner MM, Heighway J, Betticher DC.

Lung Cancer. 2001 Aug-Sep;33(2-3):229-39.

PMID:
11551418
7.

RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.

Wang H, Yang Z, Liu C, Huang S, Wang H, Chen Y, Chen G.

Biochem Biophys Res Commun. 2014 Nov 7;454(1):71-7. doi: 10.1016/j.bbrc.2014.10.023. Epub 2014 Oct 14.

PMID:
25445601
9.

Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins.

Hedberg Y, Ljungberg B, Roos G, Landberg G.

Int J Cancer. 2004 Mar 20;109(2):189-93.

10.

HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.

Hamid SM, Cicek S, Karamil S, Ozturk MB, Debelec-Butuner B, Erbaykent-Tepedelen B, Varisli L, Gonen-Korkmaz C, Yorukoglu K, Korkmaz KS.

Mol Cell Endocrinol. 2014 Mar 5;383(1-2):38-47. doi: 10.1016/j.mce.2013.12.003. Epub 2013 Dec 8.

PMID:
24325868
11.

Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.

Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH.

Oncogene. 2001 May 24;20(23):2927-36.

12.

Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.

Isobe T, Hattori T, Kitagawa K, Uchida C, Kotake Y, Kosugi I, Oda T, Kitagawa M.

J Biol Chem. 2009 Oct 9;284(41):27766-79. doi: 10.1074/jbc.M109.006809. Epub 2009 Aug 13.

13.
14.

Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.

Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T.

Cancer. 2007 Jun 15;109(12):2506-14.

15.

[The cyclin A, B1, D1 and E expression in advanced non-small cell lung cancer--stages IIIB-IV (preliminary report)].

Kosacka M, Piesiak P, Porebska I, Korzeniewska A, Jankowska R.

Pol Merkur Lekarski. 2011 Apr;30(178):253-8. Polish.

PMID:
21595169
16.

[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].

Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J.

Cancer Radiother. 2001 Apr;5(2):109-29. Review. French.

PMID:
11355576
17.

Location, location, location: the role of cyclin D1 nuclear localization in cancer.

Gladden AB, Diehl JA.

J Cell Biochem. 2005 Dec 1;96(5):906-13. Review.

PMID:
16163738
18.
19.

Construction of a cyclin D1-Cdk2 fusion protein to model the biological functions of cyclin D1-Cdk2 complexes.

Chytil A, Waltner-Law M, West R, Friedman D, Aakre M, Barker D, Law B.

J Biol Chem. 2004 Nov 12;279(46):47688-98. Epub 2004 Sep 7.

20.

HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.

Jung KH, Noh JH, Kim JK, Eun JW, Bae HJ, Xie HJ, Chang YG, Kim MG, Park H, Lee JY, Nam SW.

J Cell Biochem. 2012 Jun;113(6):2167-77. doi: 10.1002/jcb.24090.

PMID:
22492270

Supplemental Content

Support Center